phase readout
savePhase 2 primary completion: DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
March 1, 2030updated 22d ago
community read0 votes
Sponsor: Diakonos Oncology Corporation. Status: Recruiting. Conditions: Glioblastoma (GBM). NCT06805305.
view source ↗Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that